Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Nexium Case Study: Using Public Relations to Reach Diverse Patient Populations and Build Bridges Between Product Generations

Published by: Best Practices, LLC

Published: Oct. 1, 2008 - 19 Pages


Table of Contents


Executive Summary

Nexium Profile

Build Bridges between Product Generations

Public Relations Support Identity

Provide Info Support throughout the Customer Lifecycle

Employ Information Alerts

Use Referral Mechanisms

Education Tools

Educate, Inform & Engage Patients

Engage Patients on Lifestyle Fronts

Employ Podcast Technologies

New PR Media Create New Channels to Reach New Patient Populations

PR Campaigns

Celebrity Spokesman

PR Builds Bridges to Next Generation of Successor Products

About Best Practices

Abstract

STUDY OVERVIEW

This case study reviews the public relations strategy and tactics utilized by AstraZeneca for Nexium, its product for acid reflux disease. Nexium, a Gastroesophageal Reflux Disease (GERD) treatment, employed integrated PR and marketing communication strategies to launch Nexium as the successor to Prilosec, AstraZeneca’s first GI Blockbuster. After establishing Nexium as the new purple pill, AZ public relations campaigns used Internet-based tools such as alerts and resource support strategies to seed and grow patient relationships during the product’s growth years. Other Web-based PR campaigns used education tools such as polls and diet tips to engage patients. The company also used Podcast technologies and a celebrity spokesman to spread the word about Nexium. AZ marketing and PR savvy offer a case example of effective product generation succession marketing - Nexium hit blockbuster status in its second year on the market.

KEY TOPICS
  • Employ product transition to bridge from first generation to second generation.
  • Employ relationship strategies to create loyal customers throughout the product lifecycle.
  • Employ referral strategies among families and users.
  • Employ podcast and other new technologies to extend education to patient populations.
  • Create tools to help patients self-diagnose and have effective meetings with their physicians.
SAMPLE LESSONS LEARNED
  • Building Bridges: Integrated PR and communication strategies helped AstraZeneca and Eli Lilly build sturdy bridges from Prilosec to Nexium and from Prozac to Cymbalta. This “bridge building” requires good planning and ideally should commence at the back end of the first generation’s product lifecycle.
  • Timing of the Bridge Building: Field findings revealed that on average, successor products should commence PR two years prior to the new product’s global launch. Some recommended three years lead time. Nexium succeeds Prilosec as a leading blockbuster for treatment of GERD.
METHODOLOGY

The data for this case study was collected utilizing secondary research.

INDUSTRIES PROFILED

Pharmaceutical

COMPANIES PROFILED

AstraZeneca

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options
See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009